The osteocytes-derived fibroblast growth factor 23 (FGF23), principally implicated in phosphate and vitamin D regulation, is considered a promising and early CKD biomarker, which starts to increase from the beginning of renal diseases (3–5). Here, FGF23 is linked to chronic kidney disease.